rs398123341
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP5BS2
The NM_000381.4(MID1):āc.1663A>Gā(p.Ile555Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,199,830 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000381.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MID1 | NM_000381.4 | c.1663A>G | p.Ile555Val | missense_variant | 10/10 | ENST00000317552.9 | NP_000372.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MID1 | ENST00000317552.9 | c.1663A>G | p.Ile555Val | missense_variant | 10/10 | 1 | NM_000381.4 | ENSP00000312678 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 112000Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34164
GnomAD3 exomes AF: 0.00000558 AC: 1AN: 179208Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65020
GnomAD4 exome AF: 0.00000919 AC: 10AN: 1087830Hom.: 0 Cov.: 28 AF XY: 0.00000566 AC XY: 2AN XY: 353490
GnomAD4 genome AF: 0.0000268 AC: 3AN: 112000Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34164
ClinVar
Submissions by phenotype
X-linked Opitz G/BBB syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Human Genetics, Inc, Center for Human Genetics, Inc | Nov 01, 2016 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 19, 2023 | Variant summary: MID1 c.1663A>G (p.Ile555Val) results in a conservative amino acid change located in the SPRY domain (IPR001870) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2.7e-05 in 111076 control chromosomes (i.e., 2 heterozygous females and 1 hemizygous male; gnomAD v3.1.2). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1663A>G has been reported in the literature in at least one hemizygote affected with Opitz G/BBB syndrome (e.g., Ferrentino_2007). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication was ascertained in the context of this evaluation (PMID: 17221865). One submitter has reported clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at